A recent study conducted within the Department of Neurology at University Hospital in Zurich, Switzerland, determined that applying the PICOS (primary, immobilization, chemotherapy, obesity, steroid) score is more effective than current venous thromboembolism (VTE) risk estimation models for cancer patients. Of the 811 patients with brain metastases analyzed in this study, 97 (12%) experienced VTE. As a result of these findings, the authors concluded that PICOS "may be useful for stratification in controlled studies...to identify patients with brain metastasis at high risk for VTEs."
To read more about this study, click here.
Study mentioned:
Wolpert F, Berghoff AS, Grossenbacher B, et al. Venous thromboembolic events in patients with brain metastases: the PICOS score. European Journal of Cancer2020; 134:P75-85. DOI: https://doi.org/10.1016/j.ejca.2020.04.018.
No comments:
Post a Comment